Therapeutic Advances in Musculoskeletal Disease

A gold open access peer-reviewed journal publishing high-quality articles across all areas of rheumatology, osteoporosis and related disciplines. IF=4.2

[Therapeutic Advances in Musculoskeletal Disease @TAMuscDis]

Thank you for such a thought-provoking and comprehensive congress #EULAR2024! See you next year in Barcelona

[Therapeutic Advances in Musculoskeletal Disease @TAMuscDis]

An interesting late-breaking abstract from our Editor-in-Chief
@DrPoddubnyy
on the last day of #EULAR2024 presenting a novel study design to test treat-to-target for patient's with #AxialSpondyloarthritis

[Therapeutic Advances in Musculoskeletal Disease @TAMuscDis]

Looking forward to #EULAR2024 Day 3!

[Therapeutic Advances in Musculoskeletal Disease @TAMuscDis]

Fantastic talk from Prof. Neil Basu at #EULAR2024 this morning on how partitioning musculoskeletal conditions into distinct pain mechanisms is not the most effective way to treat a patient's pain

[Therapeutic Advances in Musculoskeletal Disease @TAMuscDis]

Exciting new research on pre-diagnostic proteomic biomarkers for #Gout and predictive biomarkers for treatment response in #RheumatoidArthritis (and more!) presented at the first abstract session of #EULAR2024 yesterday!

Co-moderated by our Associate Editor @ChristianDejaco

[Therapeutic Advances in Musculoskeletal Disease @TAMuscDis]

A great first day at #EULAR2024. Especially @Lupusreference's engaging and accessible talk about what's on the horizon for #Lupus.

[Therapeutic Advances in Musculoskeletal Disease @TAMuscDis]

Using natural language processing to explore characteristics and management of patients with SpA (axSpA and PsA) in Spain. Check it out here: https://t.co/qfOF99f76y @DiegoBenavent

[Therapeutic Advances in Musculoskeletal Disease @TAMuscDis]

Introducing our NEW Special Collection on Artificial Intelligence in Rheumatology!
📢 Open for submissions! Share your insights with us! 📝👩‍💻 #AI #Rheumatology @DiegoBenavent @vincevenerito @xabiermich

[Therapeutic Advances in Musculoskeletal Disease @TAMuscDis]

A new Special Collections is underway!
Psoriatic arthritis: Clinical, Diagnostic, and Therapeutic Aspects.
Guest Editors: @FragoulisGeorge @SteZhao
Find out more here: https://t.co/Tm8d1CenVL

[Lilly Medical US @LillyMedical]

Now published in @TAMuscDis: The effect of an IL-17A inhibitor on axial manifestations in patients with psoriatic arthritis from two Phase III clinical studies, SPIRIT-P1 and SPIRIT-P2. #PsA #psoriaticarthritis

Click here to access the full article: https://t.co/aCSkC3jnkz

[Therapeutic Advances in Musculoskeletal Disease @TAMuscDis]

How can we improve outcomes for PsA patients? Read more for the HIPPOCRATES programme. https://t.co/KldN299eDd @StefanSiebert1

[Therapeutic Advances in Musculoskeletal Disease @TAMuscDis]

Ixekizumab is effective in patients with Axial-PsA. Results from two phase III trials.
https://t.co/VHlwknxS8Q @DrPoddubnyy

[Therapeutic Advances in Musculoskeletal Disease @TAMuscDis]

New study shows Abatacept remains effective & safe in RA patients with previous malignancy, challenging previous inconsistent reports. 🩺🔬 #RheumatoidArthritis #MedicalResearch #abatacept
Check this out!
https://t.co/ubZfRSf4xd

[Therapeutic Advances in Rare Disease @TARareDisease]

We are celebrating today as Therapeutic Advances in Rare Disease is now indexed in PubMed & Scopus!

A great milestone for the Journal!

Congratulations @Urvalind @maurizioscarpa @BCH_Rare @JemimaMellerio @votrubam @MariyaMoosajee @oligogirl @roon_mom @DrJohnBladen @SageJournals

[Therapeutic Advances in Musculoskeletal Disease @TAMuscDis]

���� Excited to be part of #EULAR2023! We've curated a special collection of articles just for this conference. Share knowledge, foster connections, spark dialogues. Let's change the future together! 📷#Rheumatology #OpenAccess @SageClinMed
➡️https://t.co/jKjXXIMIUi

[Alina DIMA @drALINAdima]

10000 views reached !!! 🎉🎉🎉🎉🎉

Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge @TAMuscDis

Dima Alina, Jurcut Ciprian, Chasset Francois, Felten Renaud, Arnaud Laurent

https://t.co/JUsckEP1W5

[Therapeutic Advances in Chronic Disease @TAChronicDis]

New article online!

Risk factors for the long-term incidence and progression of knee osteoarthritis in older adults: role of nonsurgical injury

https://t.co/O3R6OBfERr

@SageClinMed @TAMuscDis

#OpenAccess #Osteoarthritis #KneeOsteoarthritis #TASeries #RheumTwitter

[Therapeutic Advances in Musculoskeletal Disease @TAMuscDis]

Any use of DMARDs in hand OA? Check out this updated review published in TAMD
https://t.co/5LCJSObhHR

[Therapeutic Advances in Musculoskeletal Disease @TAMuscDis]

🔬 Years of research, still no effective disease-modifying #osteoarthritis drugs (DMOADs) 💊. #MRI could be the key to success in future DMOAD trials.
@ali_guermazi @FrankRoemer1 Michel D. Crema, Mohamed Jarraya, Ali Mobasheri, Daichi Hayashi
Read more ➡️https://t.co/mfj6XJtoho

[Therapeutic Advances in Musculoskeletal Disease @TAMuscDis]

📢 New review highlights the urgent need for more effective treatments for hand #osteoarthritis. 🦴💊
From Sara Tenti, @olibruyere, Sara Cheleschi, Jean-Yves Reginster, @ilmannato, Antonella Fioravanti
https://t.co/nie2J0EWHY